Charles River Laboratories International (CRL) Treasury Shares (2009 - 2026)
Charles River Laboratories International (CRL) posted Treasury Shares of $323.2 million for Q2 2026, up 53.91% on a QoQ basis from $210.0 million in Q1 2026, and down 11.05% year-over-year from $363.3 million in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Treasury Shares (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Treasury Shares for 18 years, with the latest figure at $323.2 million in Q2 2026.
- On a quarterly basis, Treasury Shares fell 11.05% year-over-year to $323.2 million in Q2 2026; TTM through Jun 2026 was $323.2 million, a 11.05% decrease from a year earlier, with the FY2018 full-year figure at $55000.0, down 100.0% from the prior year.
- Treasury Shares was $323.2 million for Q2 2026 at Charles River Laboratories International, up from $210.0 million in the prior quarter.
- The five-year high for Treasury Shares was $2.1 million in Q2 2025, with the low at $42000.0 in Q1 2024.
- Average Treasury Shares over 5 years is $765642.9, with a median of $129000.0 recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares slumped 50.82% in 2024, then soared 3712.97% in 2025.
- Over 5 years, Treasury Shares stood at $38.5 million in 2022, then tumbled by 37.61% to $24.0 million in 2023, then jumped by 398.09% to $119.6 million in 2024, then jumped by 203.82% to $363.4 million in 2025, then decreased by 11.07% to $323.2 million in 2026.
- The last three Treasury Shares figures came in at $323.2 million (Q2 2026), $210.0 million (Q1 2026), and $363.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 95.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 69,593.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.82 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | -1.14 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 120,333.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 1.82 Mn |
| Jun 27, 2026 | 323.19 Mn |
| Jun 27, 2026 | 1.82 Mn |
| Jun 27, 2026 | 323.19 Mn |
| Mar 28, 2026 | 1.18 Mn |
| Mar 28, 2026 | 209.99 Mn |
| Mar 28, 2026 | 209.99 Mn |
| Mar 28, 2026 | 1.18 Mn |
| Sep 27, 2025 | 2.14 Mn |
| Sep 27, 2025 | 363.43 Mn |
| Sep 27, 2025 | 2.14 Mn |
| Sep 27, 2025 | 363.43 Mn |
| Jun 28, 2025 | 2.14 Mn |
| Jun 28, 2025 | 363.34 Mn |
| Jun 28, 2025 | 363.34 Mn |
| Jun 28, 2025 | 2.14 Mn |
| Mar 29, 2025 | 356.55 Mn |
| Mar 29, 2025 | 2.09 Mn |
| Mar 29, 2025 | 2.09 Mn |
| Mar 29, 2025 | 356.55 Mn |